Trial · NCT04007562
Registered outcomes19
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 19 of 19
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Creatine kinase dosage in plasma | 36 months | |
| Primary | Inflammatory cytokines in plasma | 36 months | Quantitative flow cytometry based mutliplex assays (flow cytometry-based systems (BD™ Cytometric Bead Array)). |
| Primary | Quantification of mitochondrial DNA in plasma | 36 months | Quantitative PCR to detect mitochondrial DNA, 12s gene. |
| Secondary | Occurrence of intercurrent event | 36 months | Clinical examination. |
| Secondary | Occurrence of rash | 36 months | Clinical examination. |
| Secondary | Gowers sign appearance | 36 months | Clinical examination. |
| Secondary | Occurrence of shortness of breath | 36 months | Clinical examination. |
| Secondary | Occurrence of muscular fatigability | 36 months | Clinical examination. |
| Secondary | Treatment compliance | 36 months | Patient interrogation. |
| Secondary | Occurrence of adverse effect | 36 months | Patient interrogation. |
| Secondary | Dosing of Hydroxychloroquine Sulfate in plasma | 36 months | Compliance. |
| Secondary | Occurence of retinopathy. | 36 months | Fundus eye and electroretinogram. |
| Secondary | Quotation of the different muscles | 36 months | Muscle testing by a physiotherapist. |
| Secondary | 6-min walking test | 36 months | |
| Secondary | Test of the number of steps during a 3-min walk | 36 months | |
| Secondary | Assessment of pain: VAS | 36 months | Visual analogue scale (VAS) : scale from 1 to 10; compare from one examination to another for a patient (which is his own control). |
| Secondary | Quality-of-life assessment: Pediatric Quality of Life InventoryTM (PedsQL) questionnaire | 36 months | Pediatric Quality of Life InventoryTM (PedsQL) questionnaire adapted to age: child questionnaire and parent questionnaire. Questionnaire of 23 questions scored on 5 points, from 0 (never) to 4 (almost always). The scores are linearly transformed on a scale between 0 and 100, added together and divided by the number of items completed; high scores are associated with a better quality of life related to health. |
| Secondary | Echocardiography | 36 months | Measurement of the wall of the ventricles, ejection fraction. |
| Secondary | Absence of cardiac arrhythmia | 36 months | Electrocardiography |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT04007562/registered